Navigation Links
Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus

mmune disease activity.

LymphoStat-B was generated by HGS through a collaboration with Cambridge Antibody Technology. It has received a "fast-track product" designation from the FDA for its potential use in treating SLE and has been selected for participation in the FDA's Continuous Marketing Application Pilot 2 Program, in which the FDA provides companies with more extensive feedback to improve the efficiency of the drug development and approval process. The FDA and the European Agency for the Evaluation of Medicinal Products have agreed that the Phase 3 trial design is suitable to support regulatory submissions and potential approval for marketing.

For links to scientific presentations and posters referenced, or for more information about LymphoStat-B, visit www.hgsi.com/products/LSB.html.

About the Collaboration with GSK

In August 2006, HGS and GSK entered into a definitive co-development and co-commercialization agreement under which HGS has responsibility for conducting the LymphoStat-B Phase 3 trials, with assistance from GSK. The companies will share equally in Phase 3/4 development costs, sales and marketing expenses, and profits of any product commercialized under the agreement.

About Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic, life-threatening disease. The Lupus Foundation of America estimates that approximately 1.5 million Americans suffer from various forms of lupus, including SLE. More than 300,000 people are afflicted with SLE in the United States alone. Lupus can occur at any age, but appears mostly in young people between the ages of fifteen and forty-five. About 90 percent of the individuals diagnosed with lupus are women. African-American women are about three times more likely to develop lupus, and it is also more common in Hispanic, Asian and American Indian women. Symptoms may include extreme fatigue, p
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
9. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
Post Your Comments:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... England , August 20, 2014 ... be Conducted in the US  KalVista Pharmaceuticals ... macular edema (DME), today announces that it has begun ... novel plasma kallikrein inhibitor, KVD001, for the treatment of ... Sun of the Beetham Eye Institute, Joslin Diabetes Center; ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... 2011 Insmed Incorporated (Nasdaq: INSM ), a ... call on Thursday, March 10th, 2011, at 8:30 AM EST, ... year-end 2010.  Insmed intends to issue its quarterly and year-end ... 10th. To participate in the live conference ...
... 23, 2011 Reportlinker.com announces that a new ... Global Fetal Monitors Industry ... report analyzes the worldwide markets for Fetal Monitors ... Antepartum Monitors, and Intrapartum Monitors. The report provides ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call 2
(Date:8/21/2014)... AZ (PRWEB) August 21, 2014 Drake ... have donated $10,000 to support ovarian cancer research, according ... Cundiff, who is also the kicker for the Cleveland ... Cancer Event was matched by Colleen’s Dream Foundation and ... MD, an Assistant Professor in the Division of Gynecologic ...
(Date:8/21/2014)... 2014 InSilico Medicine, a ... addressing the challenges of a rapidly aging ... signalome-wide pathway analysis. This new method ... of gene expression data obtained using high-throughput ... the journal Frontiers in Molecular Biosciences, shows ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses manufacturer ... wedding dresses. And all these elegant, gorgeous and beautiful ... designers. , A wedding dress or wedding gown is ... ceremony. Color, style and ceremonial importance of the gown ... wedding participants. In order to satisfy every customer, Fecbek.com ...
(Date:8/20/2014)... Most people think of donating food around the ... for a variety of reasons—thus making these months some ... need, Dr. Bryne Willey of AlignLife of Springfield ... wanted to heighten awareness of the need in the ... in July food drive to collect non-perishable foods for ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and women’s clothes, ... online. Along with this, the company has also launched ... fresh products are offered with great discounts and low shipping ... before August 31. , Skmen.com has more than 200 ... proportion of its clothes are selling well in the current ...
Breaking Medicine News(10 mins):Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2
... cancer will be the single leading cause of death ... stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis ... occur in developing countries, with more than a million ... Health Organization projections. , , Scot Remick, M.D., ...
... Speaker Nancy Pelosi spoke on the House floor this morning in ... Drug Administration (FDA) with authority to regulate tobacco products. The ... It passed the Senate yesterday and now goes to President ... remarks. , , "It,s really a ...
... 12 The following is a statement from Georges ... Health Association: , , "With today,s House passage of ... regulate tobacco products, our nation has finally turned the corner. ... to market their deadly products to our children and deceive ...
... HLS ) announced today that its board of ... share on its 6.5% Series A Convertible Perpetual Preferred Stock, ... July 1, 2009. , , About HealthSouth ... rehabilitative healthcare services. Operating in 26 states across the country ...
... association remains unclear, however, researchers say, , FRIDAY, June 12 ... the eye sometimes points outward are more likely to develop ... , About 1 percent of developmentally healthy U.S. children are ... line up and one looks away from the nose at ...
... N.Y., June 12 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, announced today that it has purchased three patents ... ProRhythm, Inc. The patents relate to HIFU transducer ...
Cached Medicine News:Health News:WVU Doctor Works to Reduce Cancer Burden in Africa 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 3Health News:Kids With Eye Condition at Risk for Poor Mental Health 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 3
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
Cancellous or trabecular bone that is crushed - particle size varies - primarily from distal femur, condyles, proximal tibia, femoral head, distal tibia and humeral head. Demineralized cancellous is ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Dedicated ENT electromagnetic surgical navigation system. Value priced for comunity hospitals and surgical centers....
Medicine Products: